✦ LIBER ✦

Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets

✍ Scribed by Zádori, Dénes (author);Veres, Gábor (author);Szalárdy, Levente (author);Klivényi, Péter (author);Toldi, József (author);Vécsei, László (author)

Book ID: 121822975
Publisher: IOS Press
Year: 2014
Tongue: English
Weight: 332 KB
Volume: 42
Category: Article
ISSN: 1387-2877
DOI: 10.3233/JAD-132621

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glutamatergic Dysfunctioning in Alzheime

Glutamatergic Dysfunctioning in Alzheimer's Disease and Related Therapeutic Targets

✍ Zádori, Dénes (author);Veres, Gábor (author);Szalárdy, Levente (author);Klivényi 📂 Article 📅 2014 🏛 IOS Press 🌐 English ⚖ 332 KB

Glia-related pathomechanisms in Alzheime

✍ Peter Schubert; Tadanori Ogata; Cristina Marchini; Stefano Ferroni 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Alzheimer's disease: molecular concepts

Alzheimer's disease: molecular concepts and therapeutic targets

✍ K. Fassbender; C. Masters; K. Beyreuther 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 82 KB

Some molecular mechanisms of dopaminergi

Some molecular mechanisms of dopaminergic and glutamatergic dysfunctioning in Parkinson’s disease

✍ Dénes Zádori, Levente Szalárdy, József Toldi… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 327 KB

Targeting Synaptic Dysfunction in Alzhei

Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy

✍ Nisticò, Robert; Pignatelli, Marco; Piccinin, Sonia; Mercuri, Nicola B.; Colling 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 494 KB

Adverse psychological impact, glutamater

Adverse psychological impact, glutamatergic dysfunction, and risk factors for Alzheimer's disease

✍ Trond Myhrer 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 87 KB